Dear colleague,
Methotrexate (MTX) is still our anchor drug used in Patients with Rheumatoid Arthritis. Nevertheless, the prescription patterns of MTX vary across centres and countries. As part of Horizon Europe project SQUEEZE, we aim to assess local practice of methotrexate (MTX) initiation and titration scheme in patients with rheumatoid arthritis (RA) across Europe.
We are inviting all physicians treating patients with rheumatoid arthritis across different European countries and hospital/practice settings to take part in this survey. If you have already filled in the survey we thank you for your valuable contribution.
It will take approximately 10-15 minutes to complete the survey. You can save and return to your answers at any time (if you are not able to finish it at one time point or if you want to correct some of your responses). Please note the link needs to be completed from the same device, if you want to fill out more than one survey this needs to be done on different computers. Please make sure you do not leave the survey half completed. We would like to emphasize that there are no right or wrong answers.
You can contribute to research by simply using the link:
https://de.surveymonkey.com/r/F7Q6LY3
We hope you are interested to be engaged as an expert in this project.
Please also forward this invitation to all your colleagues and encourage them to fill in the survey. The Survey will close on December 31st 2024.
